Antibodies induced by mRNA COVID-19 vaccines keep improving in quality for at least six months while the immune system continues to “train” its antibody-producing B cells, according to a new study. In other research, dysfunctional red blood cells contribute to the blood vessel injuries common in severe COVID-19, according to laboratory studies that also may suggest a way to treat the problem.
Cyrus Biotechnology announced that the Seattle-based biotechnology firm’s pre-clinical stage COVID therapeutic lead molecule, ACE2.v2.4 strongly binds the spike protein of SARS-CoV-2 variant of concern (VOC) omicron.
Healthcare disruptions linked to the coronavirus pandemic helped malaria kill 69,000 more people in 2020 than the previous year, but a worst-case scenario was averted, the World Health Organization said on December 6.
U.S. deaths from the coronavirus pandemic surged past 2,000 for two days in a row as the most dangerous season of the year approached, taxing an overwhelmed healthcare system with U.S. political leadership in disarray.
Arteric is a digital marketing agency that serves life science and healthcare brands throughout their life-cycle, from digital recruitment of participants for clinical trials through commercialization and healthcare delivery. According to management, 2019 and 2020 have been breakout years for the agency.
In a first, heart surgeons in Poland used 3D goggles to help them see inside a patient’s chest as they opened up a narrowed heart valve, according to a report in the European Heart Journal.